RE: RE: RE: RE: RE: News Leak?? Alere continues to diligently advance the research and development program and meet critical milestones under the development plan. In maintaining its exclusive option on Miraculins' technology, Alere has retained the ongoing right to exercise its option to license and commercialize the technology at any time during the option period. Upon exercise of the option, Miraculins will receive additional fees, developmental and commercial milestones and royalties on sales.